ACM  >> Vol. 5 No. 3 (September 2015)

作者:  

黄德沛,黄韵红:贵州省肿瘤医院,贵州 贵阳

关键词:
中枢神经系统淋巴瘤临床特征预后治疗大剂量甲氨蝶呤化疗Central Nervous System Lymphoma Clinical Features Prognosis Treatment High-Dose Methotrexate Chemotherapy

摘要:

目的:分析11例中枢淋巴瘤的临床特点及预后。方法:收集我院2007年至2013年11例原发性中枢神经系统淋巴瘤患者的临床资料进行回顾性分析,并参考近年来国内外文献,对原发中枢神经系统淋巴瘤的临床特征及其疗效预后进行探讨。结果:11例患者经放化疗结合治疗后并随访暂无复发,3例患者术后放化疗治疗后复发在化疗并随访中,患者恢复良好。11例患者5年总生存率OS为50%。结论:原发中枢神经系统淋巴瘤早期临床诊断困难,明确病理类型后,大剂量甲氨蝶呤化疗是其主要治疗方法,并同步放化疗的综合治疗措施,能提高患者生存质量,延长生存期。

Purpose: Study of clinical features and prognosis of 11 CNS (central nervous system) lymphoma cases. Methods: Discuss on the clinical features and prognosis of the CNS lymphoma by analyzing clinical files of the primary CNS lymphoma patients in our hospital from 2007 to 2013 with recent domestic and international studies for reference. Results: 11 patients temporarily show no relapse of CNS lymphoma after radiotherapies, chemotherapies and follow-up clinic visits. 3 patients relapse after radical and chemical therapies but recover well after follow-up visits in hospital. The general OS survival rate of the 11 cases is 50%. Conclusion: It is difficult to diagnose clinically of the primary CNS lymphoma at its early stage. Large dose of using methotrexate is the main treating method after diagnosis of its pathological mechanism. With synchronous radiotherapy and chemotherapy, the living quality and life span of patients would be enhanced accordingly.

文章引用:
黄德沛, 黄韵红. 原发中枢神经系统淋巴瘤[J]. 临床医学进展, 2015, 5(3): 131-135. http://dx.doi.org/10.12677/ACM.2015.53024

参考文献

[1] Clarke, J.L. and Deangelis, L.M. (2012) Primary central nervous system lymphoma. Handbook of Clinical Neurology, 105, 517-527.
[2] Read, T.E. (2007) Laparoscopic proctectomy for rectal adenocarcinoma. Journal of Surgical Oncology, 96, 660-664.
[3] Campen, C.J., Tombleson, R.L. and Green, M.R. The Journal of Neu-ro-Oncology.
[4] Kasenda, B., Schorb, E., Fritsch, K., Finke, J. and Illerhaus, G. (2012) Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma—A long-term follow-up study. Annals of Oncology, 23, 2670-2675.
[5] Kiefer, T., et al. (2011) Long-term follow-up of high-dose chemotherapy with autologous stem-cell transplantation and responseadapted whole-brain radiotherapy for newly diagnosed primary CNS lymphoma: Results of the multicenter Ostdeutsche Studiengruppe Hämatologie und Onkologie OSHO-53 phase II study. Annals of Oncology.
[6] (2010) 中枢淋巴瘤的诊断. 中国临床神经外科杂志, 12.
[7] Kleinschmidt-Demasters, B.K., Damek, D.M., Lil-Lehei, K.O., et al. (2008) Epstein-Barr virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications. Journal of Neuropathology & Experimental Neurology, 67, 103.
[8] 关建明 (2009) 原发中枢神经系统淋巴瘤17例. 2.
[9] Coifficr, B., Lepagc, E., Briere, J., et al. (2002) CHOP chemotherapy plusr iruximab companed with CHOP alone in elderhy polientg with diffuse large-B-cell lymphornd. New England Journal of Medicine, 346, 235.
[10] Schulz, H., Pels, H., Schmidt-Wolf, L., et al. (2004) Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab. Haemato Logica, 89, 753-754.
[11] (2010) 临床肿瘤学杂志, 4.
[12] 王勇, 岳晓, 朱玉方, 陶荣杰, 徐军 (2012) 替莫唑胺为主的化疗联合放疗治疗原发中枢神经系统淋巴瘤的临床观察. 中国临床肿瘤学, 23, 1930-1933.
[13] Thiel, E., Korfel, A., Martus, P., Kanz, L., Griesinger, F., Rauch, M., et al. (2010) High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): A phase 3, randomised, non-inferiority trial. Lancet Oncology, 11, 1036-1047.
[14] Cobert, J., Hochberg, E., Woldenberg, N. and Hochberg, F. (2010) Monotherapy with methotrexate for primary central nervous lymphoma has single agent activity in the absence of radiotherapy: A single institution cohort. The Journal of Neuro-Oncology, 98, 385-393.
[15] Liu, B.L., Cheng, J.X., Zhang, X., Zhang, W. and Cheng, H. (2009) Limited role of surgery in the management of primary central nervous system lymphoma (review). Oncology Reports, 22, 439-449.
[16] 易基群, 林桐榆, 何友兼, 黄慧强, 夏忠军, 夏云飞, 等 (2006) 32例原发性中枢神经系统恶性淋巴瘤临床分析及文献复习. 癌症, 4, 476-480.
[17] Rossi, D., Rasi, S., Di Rocco, A., Fabbri, A., Forconi, F., Gloghini, A., et al. (2011) The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma. Blood, 117, 2405- 2413.
[18] Ghesquieres, H., Ferlay, C., Richioud, B., Isnardi, V., Nicolas-Virlizier, E., Domnisoru, I.I., et al. (2011) Usefulness of positron emission tomography using 18F-FDG performed at diagnosis and during initial chemotherapy for imaging primary central nervous system lymphoma: A 24 immunocompetent patient’s study. Blood, 118, 694.